- Invited speaker presentation
- Open Access
Disability and quality of life in patients with different forms of migraine
© D'Amico et al. 2015
- Published: 28 September 2015
- Leisure Activity
- Life Tool
- Healthcare Intervention
- Disability Level
Migraine (M) is the seventh leading cause of years of life lost to disability (YLDs) worldwide, responsible for 2.9% of all YLDs, more than half of all YLDs attributable to neurological disorders. Its negative effects result from several studies, particularly in surveys carried out by our research group, through the application of patient oriented outcome measures (PROMS), and in their development and validation[2–4]. Administration of MIDAS (a migraine-specific tool) demonstrated that: the disability level is rather high (particularly in chronic M); social, family and leisure activities are more impaired than work activities; days spent at work with reduced effectiveness are more than days of absence[3–5]. A better understanding of the pervasive impact of migraine has been achieved using the WHODAS 2.0, a questionnaire based on the International Classification of Functioning, which captures the interaction between the individual's health status and the context of life. Our data, together with many results deriving from the application of quality of life tools (e.g., SF-36 and MSQ), showed that migraine influences physical and emotional domains, causes restriction and avoidance of activities also outside the headache episodes[6–11].
Migraine has to be considered both as a clinical and as a public health problem: therefore, at least two perspectives need to be taken into account:
1. Epidemiological and healthcare perspectives: to evaluate the burden of migraine in the population, understand patients’ needs in implementing appropriate treatments and address healthcare interventions.
2. Clinical practice and research perspectives: to assess the severity of migraine in an individual patient, to better tailor treatment plans, and eventually to evaluate their global outcome, and to assess the efficacy of new treatments in RCTs and observational studies.
Migraine is a common condition, whose impact is relevant on individuals, in terms of personal suffering and reduced health, and on societies, in terms of reduced productivity and increased costs for the health system[7, 8, 12]. The systematic use of PROMs should be encouraged both in the clinical and in the research fields, particularly in RCTs to quantify the potential benefits of treatments. Further (ongoing) research is needed to understand the potential application of the different tools in the different contexts, as well as to develop new instruments to assess the qualitative aspects of migraine-related disability, particularly in the workplace.
Part of this study was carried out with an unrestricted grant from Allergan.
- Steiner TJ, Stovner LJ, Birbeck GL: Migraine: the seventh disabler. J Headache Pain. 2013, 14: 1-10.1186/1129-2377-14-1.PubMed CentralView ArticlePubMedGoogle Scholar
- D'Amico D, Mosconi P, Genco S, et al: The Migraine Disability Assessment (MIDAS) questionnaire: Translation and reliability of the Italian version. Cephalalgia. 2001, 21: 947-952. 10.1046/j.0333-1024.2001.00277.x.View ArticlePubMedGoogle Scholar
- D';Amico D, Grazzi L, Usai S, Leonardi M, Raggi A: Disability and quality of life in headache: where we are now and where we are heading. Neurol Sci. 2013, 34: S1-S5.View ArticleGoogle Scholar
- Raggi A, Giovannetti AM, Schiavolin S, Leonardi M, Bussone G, Grazzi L, Usai S, Curone M, Di Fiore P, D'Amico D: Validating the Migraine-Specific Quality of Life Questionnaire v2.1 (MSQ) in Italian inpatients with chronic migraine with a history of medication overuse. Qual Life Res. 2014, 23 (4): 1273-7. 10.1007/s11136-013-0556-9.View ArticlePubMedGoogle Scholar
- D'Amico D, Grazzi L, Usai S, Rigamonti A, Curone M, Bussone G: Disability pattern in chronic migraine with medication overuse: a comparison with migraine without aura. Headache. 2005, 45 (5): 553-60. 10.1111/j.1526-4610.2005.05109.x.View ArticlePubMedGoogle Scholar
- Raggi A, Giovannetti AM, Quintas R, D'Amico D, Cieza A, Sabariego C, Bickenbach JE, Leonardi M: A systematic review of the psychosocial difficulties relevant to patients with migraine. J Headache Pain. 2012, 13: 595-606. 10.1007/s10194-012-0482-1.PubMed CentralView ArticlePubMedGoogle Scholar
- Raggi A, Covelli V, Leonardi M, Grazzi L, Curone M, D'Amico D: Difficulties in work-related activities among migraineurs are scarcely collected: results from a literature review. Neurol Sci. 2014, 35: S23-S26.View ArticleGoogle Scholar
- D'Amico D, Grazzi L, Curone M, Di Fiore P, Cecchini Proietti A, Leonardi M, Scaratti C, Raggi A: Difficulties in work activities and the pervasive effect over disability in patients with episodic and chronic migraine. Neurol Sci. 2015, 36: S9-S11. 10.1007/s10072-015-2130-4.View ArticleGoogle Scholar
- Leonardi M, Raggi A, Bussone G, D'Amico D: Health-related quality of life, disability and severity of disease in patients with migraine attending to a specialty headache center. Headache. 2010, 50: 1576-1586. 10.1111/j.1526-4610.2010.01770.x.View ArticlePubMedGoogle Scholar
- Raggi A, Leonardi M, Bussone G, D'Amico D: A 3-month analysis of disability, quality of life and disease course in patients with migraine. Headache. 2013, 53: 297-309. 10.1111/j.1526-4610.2012.02279.x.View ArticlePubMedGoogle Scholar
- Raggi A, Schiavolin S, Leonardi M, Giovannetti AM, Bussone G, Curone M, Di Fiore P, Grazzi L, Usai S, D'Amico D: Chronic Migraine with Medication Overuse: association between disability and quality of life measures, and impact of disease on patients” lives. J Neurol Sci. 2015, 348: 60-66. 10.1016/j.jns.2014.11.004.View ArticlePubMedGoogle Scholar
- Linde M, Gustavsson A, Stovner LJ, Steiner TJ, Barré J, Katsarava Z, Lainez JM, Lampl C, Lantéri-Minet M, Rastenyte D, Ruiz de la Torre E, Tassorelli C, Andrée C: The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol. 2012, 19: 703-11. 10.1111/j.1468-1331.2011.03612.x.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.